July 8, 2019
Greetings from Bangalore, India.
Hope everyone had a nice long July 4th weekend.
VC firm Rock Health published its mid-year review of digital health startups. It paints an optimistic picture based on much awaited IPOs from Health Catalyst, Livongo and others. The report also presents us with a new metric, “net liquidity overhang,” which refers to VC money locked up in illiquid investments in digital health startups. The amount is $29.4 billion, counting from 2011.
Major tech firms have stepped up their efforts at self-regulation. In light of recent activism against social media platforms and the scourge of misinformation, Facebook announced they will moderate and remove posts making exaggerated claims, such as miracle cures. Major consumer genetic testing companies joined hands to form an advocacy group to push for laws to safeguard the use of consumer information.
Digital transformation in healthcare: our picks for the week
Rock Health’s mid-year review of digital health investments and the outlook for exits.
PatientsLikeMe had been looking for a buyer since it was under pressure from federal agencies to divest its investments from a Chinese VC firm.
The big players in the genetic testing space turn to self-regulation and lobbying in response to concerns about their data use practices.
False claims on health matters can be harmful to society, and Facebook will finally address this issue on their platform.
5G infrastructure will be like installing the plumbing at the turn of the 20th century.
California takes the lead on addressing a modern-day scourge – misinformation by bot.
The latest from Damo Consulting
Healthcare IT podcast: “Healthcare is not a winner-take-all industry.”
Our latest white paper looks at what successful Chief Digital Officers do to align stakeholders across the enterprise.
A surge in deals from the public sector.
A review of the financial and market performance of global technology firms in healthcare.